Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Quinolone-resistant Salmonella strains were isolated from patient samples, and several quinolone-sensitive strains were used to analyze mutations in the quinolone resistancedetermining region (QRDR) of gyrA, gyrB, parC, and parE and to screen for plasmid-mediated quinolone resistance. Among the 21 strains that showed resistance to nalidixic acid and ciprofloxacin (MIC 0.125-2.0 μg/ml), 17 strains had a mutation in QRDR codon 87 of gyrA, and 3 strains had a single mutation (Ser83 → Phe). Another cause of resistance, efflux pump regulation, was studied by examining the expression of acrB, ramA, marA, and soxS. Five strains, including Sal-KH1 and Sal-KH2, showed no increase in relative expression in an analysis using the qRT-PCR method (p < 0.05). In order to determine the genes involved in the resistance, the Sal-9 isolate that showed decreased susceptibility and did not contain a mutation in the gyrA QRDR was used to make the STM (MIC 8 μg/ml) and STH (MIC 16 μg/ml) ciprofloxacin-resistant mutants. The gyrA QRDR Asp87 → Gly mutation was identified in both the STM and STH mutants by mutation analysis. qRT-PCR analysis of the efflux transporter acrB of the AcrAB-TolC efflux system showed increased expression levels in both the STM (1.79-fold) and STH (2.0-fold) mutants. In addition, the expression of the transcriptional regulator marA was increased in both the STM (6.35-fold) and STH (21.73-fold) mutants. Moreover, the expression of soxS was increased in the STM (3.41-fold) and STH (10.05-fold) mutants (p < 0.05). Therefore, these results indicate that AcrAB-TolC efflux pump activity and the target site mutation in gyrA are involved in quinolone resistance.
Abstract
Quinolone-resistant Salmonella strains were isolated from patient samples, and several quinolone-sensitive strains were used to analyze mutations in the quinolone resistancedetermining region (QRDR) of gyrA, gyrB, parC, and parE and to screen for plasmid-mediated quinolone resistance. Among the 21 strains that showed resistance to nalidixic acid and ciprofloxacin (MIC 0.125-2.0 μg/ml), 17 strains had a mutation in QRDR codon 87 of gyrA, and 3 strains had a single mutation (Ser83 → Phe). Another cause of resistance, efflux pump regulation, was studied by examining the expression of acrB, ramA, marA, and soxS. Five strains, including Sal-KH1 and Sal-KH2, showed no increase in relative expression in an analysis using the qRT-PCR method (p < 0.05). In order to determine the genes involved in the resistance, the Sal-9 isolate that showed decreased susceptibility and did not contain a mutation in the gyrA QRDR was used to make the STM (MIC 8 μg/ml) and STH (MIC 16 μg/ml) ciprofloxacin-resistant mutants. The gyrA QRDR Asp87 → Gly mutation was identified in both the STM and STH mutants by mutation analysis. qRT-PCR analysis of the efflux transporter acrB of the AcrAB-TolC efflux system showed increased expression levels in both the STM (1.79-fold) and STH (2.0-fold) mutants. In addition, the expression of the transcriptional regulator marA was increased in both the STM (6.35-fold) and STH (21.73-fold) mutants. Moreover, the expression of soxS was increased in the STM (3.41-fold) and STH (10.05-fold) mutants (p < 0.05). Therefore, these results indicate that AcrAB-TolC efflux pump activity and the target site mutation in gyrA are involved in quinolone resistance.
참고문헌 (38)
- Avsaroglu MD, "Plasmid-mediated quinolone resistance conferred by qnrS1 in Salmonella enteric serovar Virchow isolated from Turkish food of avian origin", J. Antimicrob. Chemother, 60, pp.1146~1150 (2007)
- Baucheron S, "AcrAB TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob", Agents Chemother, 48, pp.3729~3735 (2004)
- Bialek-Davenet S, "Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae", J. Antimicrob. Chemother, 70, pp.81~88 (2015)
- Biedenbach DJ, "Analysis of Salmonella spp. with resistance to extendedspectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004)", Diagn. Microbiol. Infect. Dis, 54, pp.13~21 (2006)
- Capoor MR, "Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region", Epidemiol. Infect, 137, pp.871~878 (2009)
- Carrique-Mas JJ, "Trends in phage types and antimicrobial resistance of Salmonella enterica serovar Enteritidis isolated from animals in Great Britain from 1990 to 2005", Vet. Rec, 162, pp.541~546 (2005)
- Dimitrov T, "Ciprofloxacin-resistant Salmonella enterica serovar Typhi from Kuwait with novel mutations in gyrA and parC genes", J. Clin. Microbiol, 47, pp.208~211 (2009)
- Eaves DJ, "Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography", J. Clin. Microbiol, 40, pp.4121~4125 (2002)
- Eaves DJ, "Effect of mutations within the QRDR of gyrA, gyrB, parC or parE in quinoloneresistant S. enterica from humans and animals", Antimicrob. Agents Chemother, 48, pp.4012~4015 (2004)
- Galán JE, "Interactions of Salmonella with host cells: encounters of the closest kind", Proc. Natl. Acad. Sci. USA, 95, pp.14006~14008 (1998)
- Gay K, "Plasmid mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica", Clin. Infect. Dis, 43, pp.297~304 (2006)
- Giraud E, "Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies", Microb. Infect, 8, pp.1937~1944 (2006)
- Horowitz DS, "Mapping the active site tyrosine of Escherichia coli DNA gyrase", J. Biol. Chem, 262, pp.5339~5344 (1987)
- Hui YH, "Foodborne Disease Handbook: Diseases Caused by Bacteria, Vol 1" (1994), Marcel Dekker
- Jacoby GA, "Mechanism of resistance to quinolones", Clin. Infect. Dis, 41, pp.S120~S126 (2005)
- Johnson DR, "Delayed detection of an increase in resistant Acinetobacter baumannii at a Detroit hospital", Infect. Control Hosp. Epidemiol, 13, pp.394~398 (1992)
- Karczmarczyk M, "Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals", Appl. Environ. Microbiol, 77, pp.7113~7120 (2011)
- Korean Antimicrobial Resistance Monitoring System, "KCDC", Korea Centers for Disease Control and Prevention (KCDC), ~ (2011)
- Kehrenberg C, "Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS", J. Antimicrob. Chemother, 64, pp.1175~1180 (2009)
- Kehrenberg C, "Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis", J. Antimicrob. Chemother, 58, pp.18~22 (2006)
- Kern WV, "Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli", Antimicrob. Agents Chemother, 44, pp.814~820 (2000)
- Kim ES, "Prevalence of plasmid-mediated quinolone resistance determinants in cefotaxime-resistance Enterobacter cloacae isolates in Korea. Kor", J. Infect. Dis, 39, pp.289~296 (2007)
- Levy SB, "Factors impacting on the problems of antibiotic resistance", J. Antimicrob. Chemother, 49, pp.25~30 (2002)
- Li XZ, "Efflux-mediated drug resistance in bacteria", Drugs, 64, pp.159~204 (2004)
- Li XZ, "Efflux-mediated drug resistance in bacteria: an update", Drugs, 69, pp.1555~1623 (2009)
- Liu X, "Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals", Vet. Microbiol, 161, pp.159~168 (2012)
- Meakins S, "Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network", Microb. Drug Resist, 14, pp.31~35 (2008)
- Meyer KS, "Nosocomial outbreak of Klebsiella spp. infection resistant to late-generation cephalosporins", Ann. Intern. Med, 119, pp.353~358 (1993)
- Nikaido E, "AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals", J. Biol. Chem, 283, pp.24245~24253 (2008)
- Nordmann P, "Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae", J. Antimicrob. Chemother, 56, pp.463~469 (2005)
- O’Regan E, "Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of ramA and other global regulators", Antimicrob. Agents Chemother, 53, pp.1080~1087 (2009)
- Park CH, "Prevalence in the United States of aac(6‘)-Ib-cr encoding a ciprofloxacin modifying enzyme", Antimicrob. Agents Chemother, 50, pp.3953~3955 (2006)
- Piddock LJ, "Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals", FEMS Microbiol. Rev, 26, pp.3~16 (2002)
- Quinn T, "Multi-drug resistance in Salmonella enterica:efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters", Curr. Drug Targets, 7, pp.849~860 (2006)
- Randall LP, "Antibiotic resistance integrons and multiple antibiotic resistance in thirty-five serotypes on Salmonella enterica isolated from humans and animals in the UK", J. Antimicrob. Chemother, 53, pp.208~216 (2004)
- Rosenberg EY, "Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein", Mol. Microbiol, 48, pp.1609~1619 (2003)
- Souli M, "Emergence of extensively drug-resistant and pandrug-resistant gramnegative bacilli in Europe", Euro Surveill, 13, pp.19045~ (2008)
- Xia S, "Molecular characterization and antimicrobial susceptibility of Salmonella from infections in humans in Henan province China", J. Clin Microbiol, 47, pp.401~409 (2009)